Your browser doesn't support javascript.
loading
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.
Sasaki, Hirokazu; Mitani, Sachiko; Kusumoto, Shigeru; Marumo, Yoshiaki; Asano, Arisa; Yoshida, Takashi; Narita, Tomoko; Ito, Asahi; Yano, Hiroki; Ri, Masaki; Ishida, Takashi; Komatsu, Hirokazu; Iida, Shinsuke.
Afiliación
  • Sasaki H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Mitani S; Department of Hematology, Kainan Hospital, Yatomi, Japan.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan. skusumot@med.nagoya-cu.ac.jp.
  • Marumo Y; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Asano A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Yoshida T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Narita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Ito A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Yano H; Department of Hematology, Kainan Hospital, Yatomi, Japan.
  • Ri M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Ishida T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Komatsu H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Int J Hematol ; 110(1): 119-123, 2019 Jul.
Article en En | MEDLINE | ID: mdl-30879266
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piridazinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Trasplante de Células Madre Hematopoyéticas / Imidazoles / Mutación Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piridazinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Trasplante de Células Madre Hematopoyéticas / Imidazoles / Mutación Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2019 Tipo del documento: Article